
CAS: 179324-69-7
Molecular Formula: C19H25BN4O4
Molecular weight:384.24
Appearance:white powder
Density: 1.214g/cm3
Melting point:122-124°C
Use :Bortezomib, a novel first-in-class proteasome inhibitor, has been a major break through in the treatment of multiple myeloma. It is currently approved for the treatment of myeloma in the relapsed setting post transplant or as a second line treatment in patients unsuitable for transplantation.



